160 related articles for article (PubMed ID: 35479808)
1. Anticancer activity of pyrimidodiazepines based on 2-chloro-4-anilinoquinazoline: synthesis, DNA binding and molecular docking.
Cuartas V; Aragón-Muriel A; Liscano Y; Polo-Cerón D; Crespo-Ortiz MDP; Quiroga J; Abonia R; Insuasty B
RSC Adv; 2021 Jul; 11(38):23310-23329. PubMed ID: 35479808
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, in vitro anticancer evaluation, ADMET properties, and molecular docking of novel 5-sulfanyl substituted (thiazol-4-yl)-phosphonium salts.
Semenyuta I; Golovchenko O; Bahrieieva O; Vydzhak R; Zhirnov V; Brovarets V
ChemMedChem; 2024 Jun; ():e202400205. PubMed ID: 38847335
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and molecular docking study of novel quinoline-based bis-chalcones as potential antitumor agents.
Insuasty D; García S; Abonia R; Insuasty B; Quiroga J; Nogueras M; Cobo J; Borosky GL; Laali KK
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100094. PubMed ID: 34050547
[TBL] [Abstract][Full Text] [Related]
4. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
El-Adl K; Ibrahim MK; Alesawy MSI; Eissa IH
Bioorg Med Chem; 2021 Jan; 30():115958. PubMed ID: 33360576
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Characterization, and Biological Study of 3-Trifluoromethylpyrazole Tethered Chalcone-Pyrrole and Pyrazoline-Pyrrole Derivatives.
Kisan Rasal N; Bhaskar Sonawane R; Vijay Jagtap S
Chem Biodivers; 2021 Oct; 18(10):e2100504. PubMed ID: 34409724
[TBL] [Abstract][Full Text] [Related]
6. mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications.
Lawal B; Lee CY; Mokgautsi N; Sumitra MR; Khedkar H; Wu ATH; Huang HS
Front Oncol; 2021; 11():656738. PubMed ID: 33842373
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4',3':3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitors.
Metwally NH; Deeb EA; Hasani IW
BMC Chem; 2024 Apr; 18(1):68. PubMed ID: 38582910
[TBL] [Abstract][Full Text] [Related]
8. New pyridine-based chalcones and pyrazolines with anticancer, antibacterial, and antiplasmodial activities.
Ramírez-Prada J; Rocha-Ortiz JS; Orozco MI; Moreno P; Guevara M; Barreto M; Burbano ME; Robledo S; Crespo-Ortiz MDP; Quiroga J; Abonia R; Cuartas V; Insuasty B
Arch Pharm (Weinheim); 2024 Mar; ():e2400081. PubMed ID: 38548680
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
10. 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation.
Abou-Seri SM; Eldehna WM; Ali MM; Abou El Ella DA
Eur J Med Chem; 2016 Jan; 107():165-79. PubMed ID: 26590508
[TBL] [Abstract][Full Text] [Related]
11. Novel pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety: design, synthesis, molecular docking, and biological evaluation as potential multi-target cytotoxic agents.
Shawky AM; Ibrahim NA; Abdalla AN; Abourehab MAS; Gouda AM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1313-1333. PubMed ID: 34154478
[TBL] [Abstract][Full Text] [Related]
12. Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents.
Afzal O; Yusuf M; Ahsan MJ; Altamimi ASA; Bakht MA; Ali A; Salahuddin
Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297760
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors.
El-Adl K; El-Helby AA; Sakr H; El-Hddad SSA
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000068. PubMed ID: 32510731
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activity of new thiazolo[3,2-a]pyrimidines: DNA binding and molecular modeling study.
Hassan GS; El-Messery SM; Abbas A
Bioorg Chem; 2017 Oct; 74():41-52. PubMed ID: 28750204
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
[TBL] [Abstract][Full Text] [Related]
17. Anticancer, antimicrobial activities of quinoline based hydrazone analogues: Synthesis, characterization and molecular docking.
Katariya KD; Shah SR; Reddy D
Bioorg Chem; 2020 Jan; 94():103406. PubMed ID: 31718889
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Anticancer Effects of Brominated Plastoquinone Analogs with Promising Cytotoxic Activity in MCF-7 Breast Cancer Cells via Cell Cycle Arrest and Oxidative Stress Induction.
Jannuzzi AT; Yilmaz Goler AM; Bayrak N; Yıldız M; Yıldırım H; Karademir Yilmaz B; Shilkar D; Venkatesan RJ; Jayaprakash V; TuYuN AF
Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890076
[TBL] [Abstract][Full Text] [Related]
19. New Paracyclophanylthiazoles with Anti-Leukemia Activity: Design, Synthesis, Molecular Docking, and Mechanistic Studies.
Aly AA; Bräse S; Hassan AA; Mohamed NK; Abd El-Haleem LE; Nieger M; Morsy NM; Abdelhafez EMN
Molecules; 2020 Jul; 25(13):. PubMed ID: 32645912
[TBL] [Abstract][Full Text] [Related]
20. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
